Zbigniew Pasieka
About
In The Last Decade
Zbigniew Pasieka
48 papers receiving 527 citations
Peers
Comparison fields: 5 of 97
- Molecular Biology 144
- Biomaterials 125
- Surgery 110
- Endocrinology, Diabetes and Metabolism 102
- Cancer Research 86
Countries citing papers authored by Zbigniew Pasieka
This map shows the geographic impact of Zbigniew Pasieka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zbigniew Pasieka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zbigniew Pasieka more than expected).
Fields of papers citing papers by Zbigniew Pasieka
This network shows the impact of papers produced by Zbigniew Pasieka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zbigniew Pasieka. The network helps show where Zbigniew Pasieka may publish in the future.
Co-authorship network of co-authors of Zbigniew Pasieka
This figure shows the co-authorship network connecting the top 25 collaborators of Zbigniew Pasieka. A scholar is included among the top collaborators of Zbigniew Pasieka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zbigniew Pasieka. Zbigniew Pasieka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 3 | |
| 5 | 25 | |
| 6 | 6 | |
| 7 | 1 | |
| 8 | 5 | |
| 9 | 6 | |
| 10 | 38 | |
| 11 | 28 | |
| 12 | 7 | |
| 13 | 12 | |
| 14 | 5 | |
| 15 | 83 | |
| 16 | 9 | |
| 17 | Concentration of metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in the serum of patients with benign and malignant thyroid tumours treated surgically. | 17 |
| 18 | Expression of C-ERBB2 and P65 genes and their protein products in follicular neoplasms of thyroid gland. | 6 |
| 19 | Angiogenic cytokines [bFGF, VEGF], matrix metalloproteinases [MMP-1,-2,-3,-8,-9], and tissue inhibitors of MMPs [TIMP-1,-2] in peripheral blood of patients with thyroid cancer | 1 |
| 20 | 21 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.